124 related articles for article (PubMed ID: 26946613)
1. Effect of compound Kushen injection on T-cell subgroups and natural killer cells in patients with locally advanced non-small-cell lung cancer treated with concomitant radiochemotherapy.
Zhao Z; Liao H; Ju Y
J Tradit Chin Med; 2016 Feb; 36(1):14-8. PubMed ID: 26946613
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage.
Du QC; Yang KZ; Sun XF
Chin J Integr Med; 2009 Jun; 15(3):184-8. PubMed ID: 19568710
[TBL] [Abstract][Full Text] [Related]
3. Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC.
Masotti A; Morandini G; Ortolani R; Fumagalli L
Lung Cancer; 1998 Jun; 20(3):191-202. PubMed ID: 9733054
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with non‑small cell lung cancer: A comparative study.
Xu Q; Shi NJ; Zhang H; Zhu YM
Mol Med Rep; 2017 Oct; 16(4):4445-4454. PubMed ID: 28765974
[TBL] [Abstract][Full Text] [Related]
5. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
6. Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
Multhoff G; Seier S; Stangl S; Sievert W; Shevtsov M; Werner C; Pockley AG; Blankenstein C; Hildebrandt M; Offner R; Ahrens N; Kokowski K; Hautmann M; Rödel C; Fietkau R; Lubgan D; Huber R; Hautmann H; Duell T; Molls M; Specht H; Haller B; Devecka M; Sauter A; Combs SE
Clin Cancer Res; 2020 Oct; 26(20):5368-5379. PubMed ID: 32873573
[TBL] [Abstract][Full Text] [Related]
7. Effect of Wuye Decoction on lymphocyte phenotype in patients with non-small cell lung cancer.
Zheng SL; Yang QS; Ma XH
Chin J Integr Med; 2006 Jun; 12(2):118-21. PubMed ID: 16800990
[TBL] [Abstract][Full Text] [Related]
8. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
Antonadou D; Throuvalas N; Petridis A; Bolanos N; Sagriotis A; Synodinou M
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):402-8. PubMed ID: 12957251
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
10. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
11. Clinical observation of Yiqi Qingdu prescription on the treatment of intermediate-stage and advanced non-small-cell lung cancer.
Liang Q; Tang X; Yu J; Xiong M; Zhu H; Xiong L; Zeng R; Yu P
J Tradit Chin Med; 2021 Apr; 41(2):308-315. PubMed ID: 33825412
[TBL] [Abstract][Full Text] [Related]
12. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
[TBL] [Abstract][Full Text] [Related]
13. Which has the least immunity depression during postoperative analgesia--morphine, tramadol, or tramadol with lornoxicam?
Wang ZY; Wang CQ; Yang JJ; Sun J; Huang YH; Tang QF; Qian YN
Clin Chim Acta; 2006 Jul; 369(1):40-5. PubMed ID: 16487501
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-Small-Cell Lung Cancer.
Ye L; Zhang F; Li H; Yang L; Lv T; Gu W; Song Y
Dis Markers; 2017; 2017():5727815. PubMed ID: 29434410
[TBL] [Abstract][Full Text] [Related]
15. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
Yu DP; Han Y; Zhao QY; Liu ZD
Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
[TBL] [Abstract][Full Text] [Related]
16. A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.
Sculier JP; Lafitte JJ; Berghmans T; Meert AP; Scherpereel A; Roelandts M; Van Cutsem O; Colinet B; Bonduelle Y; Giner V; Paesmans M; Leclercq N; Van Houtte P
Lung Cancer; 2018 Mar; 117():32-37. PubMed ID: 29496253
[TBL] [Abstract][Full Text] [Related]
17. Effect of neoadjuvant chemoradiation on tumor-infiltrating/associated lymphocytes in locally advanced rectal cancers.
Lim SH; Chua W; Cheng C; Descallar J; Ng W; Solomon M; Bokey L; Wong K; Lee MT; de Souza P; Shin JS; Lee CS
Anticancer Res; 2014 Nov; 34(11):6505-13. PubMed ID: 25368252
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
[No Abstract] [Full Text] [Related]
19. [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].
Hua R; Chen FX; Zhang YM; Zhou ZH; Wang SJ; Liang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):489-92. PubMed ID: 24021046
[TBL] [Abstract][Full Text] [Related]
20. [A phase II study of weekly cisplatine plus oral vinorelbine with concomittant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa)].
Locher C; Pourel N; Marin B; Vergnenègre A;
Rev Mal Respir; 2011 Jan; 28(1):58-65. PubMed ID: 21277475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
